Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is it worth trying?

Authors

  • Gonca KESK?NDEM?RC?, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Müge GÖKÇE, [MD] [PhD]
  • Deniz TU?CU, [MD] [PhD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Cengiz BAYRAM, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Sevinç GENÇ, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Gönül AYDO?AN, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital

Downloads

Download data is not yet available.

Downloads

Published

2017-11-06

How to Cite

1.
KESKİNDEMİRCİ G, GÖKÇE M, TUĞCU D, BAYRAM C, GENÇ S, AYDOĞAN G. Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is it worth trying?. Acta Medica [Internet]. 2017 Nov. 6 [cited 2024 May 18];46(1):85-6. Available from: https://www.actamedica.org/index.php/actamedica/article/view/122

Issue

Section

Letters to the Editor/Technical Note